Skip to main content
TECH logo
TECH
(NASDAQ)
Bio-Techne Corporation
$53.13-- (--)
Loading... - Market loading

Bio-Techne (TECH) Stock Price & Financial Analysis

Bio-Techne Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$51.24 - $54.79
52-Week High$72.16
52-Week Low$46.01
Open$52.01
Volume1.80M
Average Volume (3M)1.80M
Market Cap8.34B
Shares Outstanding157.00M
P/E Ratio (TTM)103.53
Forward P/E201.85
Price to Sales (P/S)6.91
Price to Book (P/B)4.18
EV/EBITDA37.40
Revenue (TTM)1.22B
Net Income (TTM)81.10M
Free Cash Flow (TTM)223.02M
EPS (TTM)$0.52
Profit Margin6.67%
Operating Margin21.18%
Return on Equity (ROE)4.03%
Debt to Equity0.14
50-Day MA$58.44
200-Day MA$57.70
52-Week Change-6.75%
Annual Dividend$0.32
Dividend Yield0.60%
Payout Ratio61.94%
Last Dividend Ex-DateFeb 13, 2026

Frequently Asked Questions About Bio-Techne

What is the current stock price for TECH?

As of the latest trading session, TECH stock trades at $53.13. The 52-week range is $46.01–$72.16, with a day range of $51.24–$54.79.

What is the P/E ratio for TECH?

Bio-Techne's trailing P/E ratio is 103.5, meaning investors pay $103.5 for every $1 of annual earnings. The forward P/E is 201.8, reflecting analyst expectations for future earnings. Bio-Techne operates in the Healthcare sector.

Does TECH pay dividends?

Yes, Bio-Techne pays a 0.60% annual dividend yield ($0.32 per share). The payout ratio is 61.9%. The last ex-dividend date was 2026-02-13.

What do analysts recommend for TECH?

Based on 6 analysts, the consensus for TECH is Strong Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of TECH?

Bio-Techne's market capitalization is $8.34B, classifying it as a mid-cap company. Bio-Techne operates in the Healthcare sector within the Biotechnology industry.